These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 7998354)

  • 21. [Gentamicin: various pharmacotherapeutic aspects in comparison with other aminoglycosides].
    de Visser NA; van Gogh H; van Miert AS
    Tijdschr Diergeneeskd; 1985 Feb; 110(4):135-42. PubMed ID: 3883571
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanisms of resistance to beta-lactams in some common Gram-negative bacteria causing nosocomial infections.
    Suárez CJ; Lolans K; Villegas MV; Quinn JP
    Expert Rev Anti Infect Ther; 2005 Dec; 3(6):915-22. PubMed ID: 16307504
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aminoglycoside/beta-lactam combinations in clinical practice.
    Leibovici L; Paul M
    J Antimicrob Chemother; 2007 Nov; 60(5):911-2. PubMed ID: 17890282
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The forgotten Gram-negative bacilli: what genetic determinants are telling us about the spread of antibiotic resistance.
    Gootz TD
    Biochem Pharmacol; 2006 Mar; 71(7):1073-84. PubMed ID: 16359640
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bacterial resistance to beta-lactams, and its prevention with combination antimicrobial therapy.
    Barriere SL
    Pharmacotherapy; 1992; 12(5):397-402. PubMed ID: 1437700
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Mobile gene cassettes and DNA integration elements ].
    Kovalevskaia NP
    Mol Biol (Mosk); 2002; 36(2):261-7. PubMed ID: 11969087
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tigecycline: in-vitro performance as a predictor of clinical efficacy.
    Hawkey P; Finch R
    Clin Microbiol Infect; 2007 Apr; 13(4):354-62. PubMed ID: 17359318
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Theoretical research for therapy of infection].
    Shimizu K
    Nihon Sanka Fujinka Gakkai Zasshi; 1991 Aug; 43(8):815-23. PubMed ID: 1655924
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro activity of ertapenem: review of recent studies.
    Wexler HM
    J Antimicrob Chemother; 2004 Jun; 53 Suppl 2():ii11-21. PubMed ID: 15150179
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The threat of antibiotic resistance in Gram-negative pathogenic bacteria: beta-lactams in peril!
    Thomson JM; Bonomo RA
    Curr Opin Microbiol; 2005 Oct; 8(5):518-24. PubMed ID: 16126451
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Toxicologic and pharmacologic considerations in the choice of empiric parenteral antibiotics.
    Glauser MP; Neftel KA
    Am J Med; 1986 May; 80(5C):64-9. PubMed ID: 3717190
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [New aspects on resistance to beta-lactam antibiotics].
    Bakken JS; Sanders CC
    Nord Med; 1987; 102(12):354-6. PubMed ID: 3697059
    [No Abstract]   [Full Text] [Related]  

  • 33. Meropenem use and colonization by antibiotic-resistant Gram-negative bacilli in a pediatric intensive care unit.
    Toltzis P; Dul M; O'Riordan MA; Melnick D; Lo M; Blumer J
    Pediatr Crit Care Med; 2009 Jan; 10(1):49-54. PubMed ID: 19057450
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intravenous colistin sulphomethate sodium for therapy of infections due to multidrug-resistant gram-negative bacteria.
    Pintado V; San Miguel LG; Grill F; Mejía B; Cobo J; Fortún J; Martín-Dávila P; Moreno S
    J Infect; 2008 Mar; 56(3):185-90. PubMed ID: 18280570
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Linezolid in the treatment of antibiotic-resistant gram-positive infections of the musculoskeletal system].
    Jahoda D; Nyc O; Pokorný D; Landor I; Sosna A
    Acta Chir Orthop Traumatol Cech; 2006 Oct; 73(5):329-33. PubMed ID: 17140514
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibiotic use in neonatal sepsis.
    Yurdakök M
    Turk J Pediatr; 1998; 40(1):17-33. PubMed ID: 9722468
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Typing of extended-spectrum beta-lactamase-producing Salmonella typhimurium strains isolated in a pediatric unit].
    Mhand RA; Soukri A; Amarouch H; Mdaghri NE; Benbachir M
    Sante; 1999; 9(6):341-4. PubMed ID: 10705312
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characteristics, epidemiology and clinical importance of emerging strains of Gram-negative bacilli producing extended-spectrum beta-lactamases.
    Shah AA; Hasan F; Ahmed S; Hameed A
    Res Microbiol; 2004; 155(6):409-21. PubMed ID: 15249058
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro activity of imipenem and six other beta-lactam antibiotics against aminoglycoside resistant gram-negative bacilli.
    Bujdáková H; Kallová J; Lausová A; Kettner M
    Microbios; 1995; 84(339):87-90. PubMed ID: 8628124
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Beta-lactam-resistance patterns of some gram-negative rods].
    Janicka G; Kania I; Białek M; Kruszyńska E; Wiktorowicz-Belzyt E; Mikucka A; Czajkowski H
    Pol Merkur Lekarski; 1999 Jan; 6(31):12-4. PubMed ID: 10344146
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.